TechBio Unicorn Owkin Teams Up with AWS to Advance Generative AI for Precision Medicine
AWS News, Thursday, February 8th, 2024
The company will leverage AWS's scalable storage options, enhanced data security measures, and robust computing capabilities to empower scientists and researchers to access, analyze, and manage vast amounts of data efficiently and securely in the cloud
Owkin, a TechBio that combines the best of human and artificial intelligence to find the right treatment for every patient, announced they are working with Amazon Web Services (AWS) to transform drug discovery, de-risk and accelerate clinical trials, and develop AI diagnostics. Owkin will leverage AWS's proven global infrastructure and secure, extensive and reliable cloud platform to enhance data operations, optimize for operational excellence, and drive forward research in precision medicine.